Brentuximab vedotin: The science of common sense

Matthew A. Lunning; Anas Younes

doi:10.3109/10428194.2013.786074

Brentuximab vedotin: The science of common sense

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2089-2090
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	54
Issue number	10
DOIs	https://doi.org/10.3109/10428194.2013.786074
State	Published - Oct 2013
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2013.786074

Cite this

@article{203414a6901847de964a0479e3274c9e,

title = "Brentuximab vedotin: The science of common sense",

author = "Lunning, {Matthew A.} and Anas Younes",

year = "2013",

month = oct,

doi = "10.3109/10428194.2013.786074",

language = "English (US)",

volume = "54",

pages = "2089--2090",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "10",

}

TY - JOUR

T1 - Brentuximab vedotin

T2 - The science of common sense

AU - Lunning, Matthew A.

AU - Younes, Anas

PY - 2013/10

Y1 - 2013/10

UR - http://www.scopus.com/inward/record.url?scp=84884470449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884470449&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.786074

DO - 10.3109/10428194.2013.786074

M3 - Comment/debate

C2 - 23517563

AN - SCOPUS:84884470449

SN - 1042-8194

VL - 54

SP - 2089

EP - 2090

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 10

ER -

Brentuximab vedotin: The science of common sense

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this